Mechanistically, our subsequent experiments in vitro and in vivo demonstrated that circ102049 promoted the CRC progression through a miR‐761/miR‐192‐3p‐FRAS1‐dependent mechanism. The gene discussed is FRAS1; the disease is colorectal carcinoma.